SCHEMBL5287538

SCHEMBL5287538

CCCCCCCCC[n+]1cc[nH]c1C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 4/20 0.46
KMT2A Q03164 4/20 0.42
MEN1 O00255 3/20 0.42
MAPT P10636 2/20 0.42
TP53 P04637 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
SMN1; SMN2 Q16637 4/20 0.41
LMNA P02545 3/20 0.41
KDM4E B2RXH2 2/20 0.41
NPC1 O15118 2/20 0.41
RAB9A P51151 2/20 0.41
RAD52 P43351 4/20 0.41
HSP90AA1 P07900 3/20 0.41
MAPK1 P28482 2/20 0.41
RGS12 O14924 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2328683 1.00 HTT (0.46) HTTKMT2AMEN1MAPTTP53
SCHEMBL5090775 1.00 HTT (0.46) HTTKMT2AMEN1MAPTTP53
SCHEMBL29726515 1.00 HTT (0.46) HTTKMT2AMEN1MAPTTP53
SCHEMBL9935730 1.00 HTT (0.46) HTTKMT2AMEN1MAPTTP53
SCHEMBL363480 1.00 HTT (0.46) HTTKMT2AMEN1MAPTTP53
SCHEMBL5086772 1.00 HTT (0.46) HTTKMT2AMEN1MAPTTP53
SCHEMBL1137199 1.00 HTT (0.46) HTTKMT2AMEN1MAPTTP53
SCHEMBL9902243 1.00 HTT (0.46) HTTKMT2AMEN1MAPTTP53
Bromide SCHEMBL17027655 0.98 HTT (0.44) HTTKMT2AMEN1MAPTTP53
Bromide SCHEMBL193259 0.98 HTT (0.44) HTTKMT2AMEN1MAPTTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 66 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250196021-A1 METHODS OF SOLVENT DISPLACEMENT FOR METAL-CONTAINING IONIC LIQUIDS CHEVRON PHILLIPS CHEMICAL COMPANY LP 2025-06-19 US claimed
WO-2025128828-A1 METHODS OF SOLVENT DISPLACEMENT FOR METAL-CONTAINING IONIC LIQUIDS CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2025-06-19 WO claimed
CN-107427758-B Separation using ionic liquid solvents 切弗朗菲利浦化学公司 2020-11-20 CN claimed
US-10227274-B2 Separations with ionic liquid solvents CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2019-03-12 US claimed
EP-3244987-A1 SEPARATIONS WITH IONIC LIQUID SOLVENTS Chevron Phillips Chemical Company LP (US) 2017-11-22 EP claimed
US-20150133711-A1 Separations With Ionic Liquid Solvents CHEVRON PHILLIPS CHEMICAL COMPANY LP 2015-05-14 US claimed
US-20260015304-A1 METAL-CONTAINING IONIC LIQUIDS WITH REDUCED VISCOSITY CHEVRON PHILLIPS CHEMICAL CO LP (US) 2026-01-15 US disclosed
US-12441671-B2 Metal-containing ionic liquids with reduced viscosity CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2025-10-14 US disclosed
US-12365647-B2 Method for preparing acrylonitrile dimer LG CHEM, LTD. (KR) 2025-07-22 US disclosed
WO-2025128828-A1 METHODS OF SOLVENT DISPLACEMENT FOR METAL-CONTAINING IONIC LIQUIDS CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2025-06-19 WO disclosed
US-20250196021-A1 METHODS OF SOLVENT DISPLACEMENT FOR METAL-CONTAINING IONIC LIQUIDS CHEVRON PHILLIPS CHEMICAL COMPANY LP 2025-06-19 US disclosed
EP-3507346-B1 ALKYLATION OF REFINERY PENTENES WITH ISOBUTANE CHEVRON USA INC (US) 2025-04-30 EP disclosed
EP-4511154-A1 METAL-CONTAINING IONIC LIQUIDS WITH REDUCED VISCOSITY Chevron Phillips Chemical Company LP (US) 2025-02-26 EP disclosed
US-20170216827-A1 REGENERATION OF ACIDIC IONIC LIQUID WITHOUT ADDITION OF A HYDROGENATION CATALYST CHEVRON U.S.A. INC. 2017-08-03 US disclosed
US-20150133711-A1 Separations With Ionic Liquid Solvents CHEVRON PHILLIPS CHEMICAL COMPANY LP 2015-05-14 US disclosed
WO-2012163490-A1 ELECTROLYTE FORMULATIONS MERCK PATENT GMBH (DE) 2012-12-06 WO disclosed
EP-1742909-A4 ANIONIC-SWEETENER-BASED IONIC LIQUIDS AND METHODS OF USE THEREOF UNIV SOUTH ALABAMA (US) 2007-10-17 EP disclosed
WO-2007006418-A1 IONIC-LIQUID-CONTAINING PRODUCTS FOR DYEING AND/OR BRIGHTENING KERATIN FIBRES HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2007-01-18 WO disclosed
EP-1742909-A2 ANIONIC-SWEETENER-BASED IONIC LIQUIDS AND METHODS OF USE THEREOF University Of South Alabama (US) 2007-01-17 EP disclosed
WO-2005072376-A2 ANIONIC-SWEETENER-BASED IONIC LIQUIDS AND METHODS OF USE THEREOF UNIVERSITY OF SOUTH ALABAMA (US) 2005-08-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170216827-A1 REGENERATION OF ACIDIC IONIC LIQUID WITHOUT ADDITION OF A HYDROGENATION CATALYST MGMT, GIGYF2, PUF60 HTT 798/4885KMT2A 2772/4885MEN1 3328/4885
US-12365647-B2 Method for preparing acrylonitrile dimer ADH1C, ADH1A, PUF60 HTT 4222/4885KMT2A 4707/4885MEN1 1928/4885
US-20260015304-A1 METAL-CONTAINING IONIC LIQUIDS WITH REDUCED VISCOSITY EXOC3, ELL, IGF2BP2 HTT 2841/4885KMT2A 3292/4885MEN1 2342/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.